LexDanaLexDanabeta
Inventor

Michael OVERSTREET

Inventor
US

Overview

2→
Patents
2024–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
Y02ATechnologies for adaptation to climate change25%
PatentTitleYear
12,570,744Bispecific PD-1 and TIGIT binding proteins and uses thereof202611,939,382Bispecific PD-1 and TIGIT binding proteins and uses thereof2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2026Patents assigned to MEDIMMUNE LLC (2)· patent assignee history
2024–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MEDIMMUNE LLC22024–2026
Locations
LocationPatentsSpan
US22024–2026